Clare Lloyd

GROUP LEADER - SATELLITE

Clare Lloyd is Professor of Respiratory Immunology, Interim Head National Heart and Lung Institute and Vice Dean for Institutional Affairs in the Faculty of Medicine, Imperial College, London. Clare completed both her BSc and PhD degrees in Immunology at King's College London. She was awarded a Junior Research Fellowship from the National Kidney Research Fund at the United Medical and Dental Schools at Guy's Hospital to study the immune response associated with mouse models of glomerulonephritis.

Thereafter she moved to the US to take up a Postdoctoral position jointly with Dr Jose-Carlos Gutierrez Ramos at Harvard University and Professor David Salant at Boston University Medical Center, developing a mouse model of chronic inflammatory glomerulonephritis. She moved to Millennium Pharmaceuticals in Cambridge, USA where her role was to develop models and systems to functionally characterise novel genes of unknown function.

Professor Lloyd moved back to the UK to establish a research group at Imperial College after being awarded a Wellcome Senior Fellow in Basic Biomedical Sciences. Her group has developed models of chronic allergic inflammation and outlined roles for cells and molecules involved in the development and regulation of pulmonary inflammation, airway hyperreactivity and airway remodelling. Her Fellowship was successfully renewed four times, and is now a Wellcome Investigator. 

Qualifications and history

1983
King's College London
BSc in Immunology
1987
King's College London
PhD in Immunology
1991
Guy's & St Thomas' Trust
Postdoctoral Fellow
1995
BUMC/Harvard University
Postdoctoral Fellow
1996
Research Scientist
Millenium Pharmaceuticals
1999
Wellcome Senior Fellow
Imperial College London
2006
Professor of Respiratory Immunology
Imperial College London
2016
Vide Dean (Institutional Affairs) Medicine
Imperial College London
2018
Satellite Group Leader
The Francis Crick Institute
2023
Interim Head NHLI
Imperial College London
Displaying 1 - 5 of 5
Last updated : 03 March 2026 02:35